Celcuity
About:
Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.
Website: http://celcuity.com
Top Investors: Blue Owl, New Enterprise Associates, RA Capital Management, Soleus Capital, Venrock Healthcare Capital Partners
Description:
Celcuity is a clinical-stage biotechnology company translating discoveries of new cancer sub-types into pioneering companion diagnostics and expanded therapeutic options for cancer patients. Celcuity's 3rd generation diagnostic platform, CELsignia, analyzes living tumor cells to untangle the complexity of the cellular activity driving a patient's cancer. This allows Celcuity to discover new cancer sub-types molecular diagnostics cannot detect. Celcuity is driven to improve outcomes for patients and to transform how pharmaceutical companies define the patient populations for their targeted therapies.
$336M
$10M to $50M
Hamel, Minnesota, United States
2012-01-01
Brian Sullivan, Lance Laing
11-50
2024-05-30
Public
© 2025 bioDAO.ai